Menu

Blog

Page 3082

Nov 4, 2022

Dominion Energy

Posted by in category: energy

A 2022 pilot proved to officials at Dominion Energy that Spot can help improve efficiency and boost worker safety.

Nov 4, 2022

New large-scale virtual model of cortex highly successful in solving visual tasks

Posted by in categories: biological, neuroscience, robotics/AI

HBP researchers have trained a large-scale model of the primary visual cortex of the mouse to solve visual tasks in a highly robust way. The model provides the basis for a new generation of neural network models. Due to their versatility and energy-efficient processing, these models can contribute to advances in neuromorphic computing.

Modeling the brain can have a massive impact on artificial intelligence (AI): since the brain processes images in a much more energy-efficient way than artificial networks, scientists take inspiration from neuroscience to create neural networks that function similarly to the biological ones to significantly save energy.

In that sense, brain-inspired neural networks are likely to have an impact on future technology, by serving as blueprints for visual processing in more energy-efficient neuromorphic hardware. Now, a study by Human Brain Project (HBP) researchers from the Graz University of Technology (Austria) showed how a large data-based model can reproduce a number of the brain’s visual processing capabilities in a versatile and accurate way. The results were published in the journal Science Advances.

Nov 4, 2022

A Dream of Discovering Alien Life Finds New Hope

Posted by in category: alien life

For Lisa Kaltenegger and her generation of exoplanet astronomers, decades of planning have set the stage for an epochal detection.

Nov 4, 2022

The shape-shifting blobs that shook up cell biology

Posted by in category: biological

More than a decade ago, scientists started finding peculiar droplets inside cells. Now researchers are trying to work out how these ubiquitous beads form and what they do.

Nov 4, 2022

Scientists Discover Huge ‘Extragalactic Structure’ in Hidden Region of Space

Posted by in category: space

The obscured “zone of avoidance” in space is a place of mystery, and scientists are peering at what’s inside it.

Nov 4, 2022

Artificial intelligence makes enzyme engineering easy

Posted by in categories: food, robotics/AI, sustainability

You can’t move a pharmaceutical scientist from a lab to a kitchen and expect the same research output. Enzymes behave exactly the same: They are dependent upon a specific environment. But now, in a study recently published in ACS Synthetic Biology, researchers from Osaka University have imparted an analogous level of adaptability to enzymes, a goal that has remained elusive for over 30 years.

Enzymes perform impressive functions, enabled by the unique arrangement of their constituent amino acids, but usually only within a specific cellular environment. When you change the cellular environment, the enzyme rarely functions well—if at all. Thus, a long-standing research goal has been to retain or even improve upon the function of enzymes in different environments; for example, conditions that are favorable for biofuel production. Traditionally, such work has involved extensive experimental trial-and-error that might have little assurance of achieving an optimal result.

Artificial intelligence (a computer-based tool) can minimize this trial-and-error, but still relies on experimentally obtained crystal structures of enzymes—which can be unavailable or not especially useful. Thus, “the pertinent amino acids one should mutate in the enzyme might be only best-guesses,” says Teppei Niide, co-senior author. “To solve this problem, we devised a methodology of ranking amino acids that depends only on the widely available amino acid sequence of analogous enzymes from other living species.”

Nov 4, 2022

Alternative Gene Splicing — Another Method of Bioengineering

Posted by in categories: bioengineering, biotech/medical, genetics

Genetic engineering is a rapidly progressing scientific discipline, with tremendous current application and future potential. It’s a bit dizzying for a science communicator who is not directly involved in genetics research to keep up. I do have some graduate level training in genetics so at least I understand the language enough to try to translate the latest research for a general audience.

Many readers have by now heard of CRISPR – a powerful method of altering or silencing genes that brings down the cost and complexity so that almost any genetics lab can use this technique. CRISPR is actually just the latest of several powerful gene-altering techniques, such as TALEN. CRISPR is essentially a way to target a specific sequence of the DNA, and then deliver a package which does something, like splice the DNA. But you also need to target the correct cells. In a petri dish, this is simple. But in living organism, this is a huge challenge. We have developed several viral vectors that can be targeted to specific cell types in order to deliver the CRIPR (or TALEN), which then targets the specific DNA.

Continue reading “Alternative Gene Splicing — Another Method of Bioengineering” »

Nov 4, 2022

Broad transcriptomic dysregulation occurs across the cerebral cortex in ASD

Posted by in category: neuroscience

ARI gene groups (ARI downregulated genes, those highly expressed in BA17 and BA39/40 relative to other regions in controls; ARI upregulated genes, those expressed at low level in BA17 and BA39/40 relative to other regions in controls) were created through taking the union (without duplicates) across all ten identified ASD-attenuated regional comparisons, and sorting genes into the two groups based on gene-expression profiles across regions. The details of this process are described in the Supplementary Methods, along with functional annotation procedures.

Standard workflows using WGCNA17 were followed as previously described in Parikshak et al.5 and Gandal et al.1 (with minor modifications) to identify gene and transcript co-expression modules. Details regarding network formation, module identification, and module functional characterization are described in the Supplementary Methods.

Frozen brain samples were placed on dry ice in a dehydrated dissection chamber to reduce degradation effects from sample thawing and/or humidity. Approximately 50 mg of cortex was sectioned, ensuring specific grey matter–white matter boundary. The tissue section was homogenized in RNase-free conditions with a light detergent briefly on ice using a dounce homogenizer, filtered through a 40-μM filter and centrifuged at 1,000 g for 8 min at 4 °C. The pelleted nuclei were then filtered through a two-part micro gradient (30%/50%) for 20 min at 4 °C. Clean nuclei were pelleted away from debris. The nuclei were washed two more times with PBS/1%BSA/RNase and spun down at 500 g for 5 min. Cells were inspected for quality (shape, colour and membrane integrity) and counted on a Countess II instrument. They were then loaded onto the 10X Genomics platform to isolate single nuclei and generate libraries for RNA sequencing on the NovaS4 or NovaS2 Illumina machines.

Nov 4, 2022

Incorporating nanoparticles into a porous hydrogel to propel an aquabot with minimal voltage

Posted by in categories: biotech/medical, nanotechnology, robotics/AI

A team of researchers from Korea University, Ajou University and Hanyang University, all in the Republic of Korea, has created a tiny aquabot propelled by fins made of a porous hydrogel imbued with nanoparticles. In their paper published in the journal Science Robotics, the group describes how the hydrogel works to power a tiny boat and reveals how much voltage was required.

Scientists and engineers have been working for several years to build tiny, soft robots for use in and have found that hydrogels are quite suitable for the task. Unfortunately, such materials also have undesirable characteristics, most notably, poor electro-connectivity. In this new effort, the researchers took a new approach to making hydrogels more amenable for use with electricity as a —adding conductive nanoparticles.

Continue reading “Incorporating nanoparticles into a porous hydrogel to propel an aquabot with minimal voltage” »

Nov 4, 2022

Ludwig Chicago nanotechnology induces therapeutic immune responses against multiple types of tumors

Posted by in categories: biotech/medical, genetics, nanotechnology

A Ludwig Cancer Research study has developed a novel nanotechnology that triggers potent therapeutic anti-tumor immune responses and demonstrated its efficacy in mouse models of multiple cancers. Led by Co-director Ralph Weichselbaum, investigator Wenbin Lin and postdoctoral researcher Kaiting Yang at the Ludwig Center at Chicago, the study describes the synthesis, mechanism of action and preclinical assessment of the nanoparticle, which is loaded with a drug that activates a protein central to the efficient induction of anti-cancer immunity. The study, which overcomes significant technical barriers to targeting that protein-;stimulator of interferon genes, or STING-;for cancer therapy, appears in the current issue of Nature Nanotechnology.

“The nanoparticles developed by the Lin lab release a drug that targets macrophages and can activate potent antitumor immune responses that extend the survival of mice bearing a variety of tumors,” said Chicago Center Co-director Weichselbaum. “When used in combination with radiotherapy and immunotherapy, they even help control ‘cold tumors’ that are otherwise almost completely impervious to immune attack.”

STING is part of cellular sensing system for DNA fragments, which are generated by infection or cancer treatments that damage DNA, like radiotherapy and some chemotherapies. Its activation promotes inflammation and drives immune cells like macrophages and dendritic cells to process and present cancer antigens to T cells, helping to stimulate and direct the immune assault on tumors. Though STING is a prized target for drug development, the drug-like molecules that can activate the molecular sensor-;known as cyclic dinucleotides (CDNs)-;have been plagued by issues of poor bioavailability, low stability and high toxicity in the absence of any means to target them specifically to tumors.